Business
Splash Beverage Group Signs Letter of Intent for Acquisition and Merger With Established Hemp and CBD Operator Medterra
Proposed Combination Marks Strategic Re-Alignment as a Public Cannabinoid Wellness Platform FORT LAUDERDALE, FL - March 5, 2026 (NEWMEDIAWIRE) - Splash Beverage Group, Inc. (NYSE American: SBEV) ("Splash" or the "Company") today announced it has exec...
About this update from Splash Beverage Group, Inc. (nv)
[{"type":"image","caption":"","headline":"Splash Beverage Group Signs Letter of Intent for Acquisition and Merger With Established Hemp and CBD Operator Medterra","size":{"original":{"width":140,"height":39,"url":"https://media.zenfs.com/en/newsmediawire_165/6d8f9695fe1e861c7706f47ce98c02a1"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/P82iwfO54RHCNGARsGLdBQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIxMDtoPTU5O2NmPXdlYnA-/https://media.zenfs.com/en/newsmediawire_165/6d8f9695fe1e861c7706f47ce98c02a1","width":140,"height":39}}},{"type":"text","content":"Proposed Combination Marks Strategic Re-Alignment as a Public Cannabinoid Wellness Platform","length":91,"tagName":"p"},{"type":"text","content":"FORT LAUDERDALE, FL - March 5, 2026 (NEWMEDIAWIRE) - Splash Beverage Group, Inc. (NYSE American: SBEV) ("Splash" or the "Company") today announced it has executed a non-binding Letter of Intent ("LOI") for a proposed merger with Medterra CBD, LLC ("Medterra"), a leading manufacturer and multi-brand operator of federally compliant cannabinoid wellness products sold to over 2 million customers across the United States and Internationally.","length":480,"tagName":"p"},{"type":"text","content":"The proposed transaction represents a transformative step in the Company's evolution and the re-alignment and branding as a growth-oriented platform focused on cannabinoid wellness, regulated consumer health, and scalable brand development through the curation of an established house of brands.","length":299,"tagName":"p"},{"type":"text","content":"Through this proposed partnership, Splash and Medterra would be positioned to drive category leadership in the emerging cannabinoid wellness market by leveraging operational scale, access to public markets, a seasoned executive team and a disciplined growth strategy focused on the curation of a house of brands that have a strong track record of delivering consistent, high-quality products to consumers. The companies also plan to participate in a CBD pilot initiative under evaluation by Centers for Medicare & Medicaid Services ("CMS"), which could represent a meaningful long-term growth opportunity, as discussed below. Additional details regarding the Company's rebranding and strategic evolution will be announced in due course.","length":754,"tagName":"p"},{"type":"text","content"...